Riskpilot← Back to searchSign inGet full accessKronobäcks Veterinärklinik AB
ABActiveOrg 5592209695Timmernabbsvägen 16Veterinary activities · NACE 7500Est. 201925 employees
Revenue 2024
SEK 24,1M
+24% vs 2023
EBITDA margin
15.4%
+44% vs 2023
Equity ratio
7.7%
Financial strength
Net profit 2024
SEK 1,2M
+132% vs 2023
| Revenue | SEK 24,1M | +24% |
| EBITDA | SEK 3,7M | +44% |
| Net profit | SEK 1,2M | +132% |
| Total assets | SEK 17,7M | +31% |
| Equity | SEK 1,4M | +87% |
| Employees | 25 | — |
Legal name
Kronobäcks Veterinärklinik AB
Org number
5592209695
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
2 oktober 2019
Share capital
SEK 50 000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Veterinärklinik med vård av smådjur samt försäljning av djurrelaterade produkter
Address
Timmernabbsvägen 16
Phone
+4649912740
Email
ida.wallin@kronobacksvet.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 585 | 10 791 | 14 189 | 19 487 | 24 101 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 305 | 1 741 | 2 952 | 2 570 | 3 707 |
| Depreciation & amort. | −171 | −547 | −811 | −1 149 | −1 178 |
| EBIT | 1 134 | 1 194 | 2 141 | 1 421 | 2 529 |
| Net financials | −75 | −395 | −474 | −631 | −933 |
| Profit before tax | 959 | 586 | 865 | 706 | 1 615 |
| Tax | −208 | −132 | −124 | −173 | −379 |
| Net profit | 751 | 454 | 741 | 533 | 1 236 |
| Item | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 935 | 12 499 | 12 675 | 13 481 | 17 703 |
| Equity | 801 | 605 | 896 | 729 | 1 365 |
| Long-term debt | 6 547 | 8 720 | 8 040 | 7 980 | 10 803 |
| Short-term debt | 1 488 | 2 860 | 2 624 | 3 572 | 4 354 |
| Total debt | 8 035 | 11 580 | 10 664 | 11 552 | 15 157 |
EBITDA margin
15.4%
This company
15.8%
Market median
+3% vs market
20212024
Equity ratio
7.7%
This company
38.2%
Market median
-80% vs market
20212024
Return on equity
90.5%
This company
18.4%
Market median
+392% vs market
20212024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20212024
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
20212024
Debt / equity
11.97×
This company
0.62×
Market median
-1831% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2019-10-01 – 2021-01-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IK Chief Executive Officer | Chief Executive Officer | 2021 |
MR Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
JS | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (2) | ||
| Board of Directors | 2021 – 2023 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kronobäcks Veterinärklinik AB 
Lindsdal Vet ABBoard members of Kronobäcks Veterinärklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Sven-Peter Eliasson | Audit | 0 companies |
| Ida Kerstin Maria Wallin | Chief Executive Officer | 0 companies |
| Mats Robert Björklund | Chief Auditor | 0 companies |
| Uira Mendonca Ramos | Deputy Board Member | 0 companies |
| Alexandra Charlotte Wilby | Board of Directors | 0 companies |
| Omar Tomas Valve | Deputy Board Member | 0 companies |